Pharmacokinetics of imipenem/cilastatin during continuous arteriovenous hemofiltration.
Przechera
M
M
Department of Nephrology, University of Tübingen, FRG.
Bengel
D
D
Risler
T
T
D058186:Acute Kidney Injury / Q000097:blood / Q000628:therapy*; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000097:blood / Q000188:drug therapy; D015377:Cilastatin / Q000493:pharmacokinetics* / Q000627:therapeutic use; D003428:Cross Infection / Q000097:blood / Q000188:drug therapy; D004359:Drug Therapy, Combination / Q000493:pharmacokinetics / Q000627:therapeutic use; D005260:Female; D006207:Half-Life; D006440:Hemofiltration; D006801:Humans; D015378:Imipenem / Q000493:pharmacokinetics* / Q000627:therapeutic use; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged
D015377:Cilastatin; D015378:Imipenem